Focosi D, McConnell S, Casadevall A, Cappello E, Valdiserra G, Tuccori M. Monoclonal antibody therapies against SARS-CoV-2. Lancet Infect Dis 2022; published online July 5. https://doi.org/10.1016/S1473-3099(22)00311-5—In this Review, the Search strategy and selection criteria panel was missing. This correction has been made to the online version as of July 12, 2022, and will be made to the printed version.
. 2022 Jul 12;22(9):e239. doi: 10.1016/S1473-3099(22)00468-6
Correction to Lancet Infect Dis 2022; published online July 5. https://doi.org/10.1016/S1473-3099(22)00311-5
Issue date 2022 Sep.
© 2022 Elsevier Ltd. All rights reserved.
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
PMCID: PMC9275794 PMID: 35839793
This corrects the article "Monoclonal antibody therapies against SARS-CoV-2" on page e311.